Therapeutic options for patients with severe β-thalassemia: The need for globin gene therapy Journal Article


Authors: Sadelain, M.; Boulad, F.; Galanello, R.; Giardina, P.; Locatelli, F.; Maggio, A.; Rivella, S.; Riviere, I.; Tisdale, J.
Article Title: Therapeutic options for patients with severe β-thalassemia: The need for globin gene therapy
Keywords: treatment outcome; busulfan; mortality; neutropenia; review; interferon; drug safety; drug withdrawal; hepatitis c; liver cirrhosis; nonhuman; side effect; drug megadose; follow up; animals; mice; disease association; quality of life; liver toxicity; gene expression; anemia; gastrointestinal symptom; morbidity; gene locus; creatinine blood level; continuous infusion; risk assessment; carcinogenesis; gene transfer; viral gene delivery system; alanine aminotransferase blood level; drug hypersensitivity; rash; hla matching; diabetes mellitus; gene therapy; lentivirus vector; beta thalassemia; globin gene; graft versus host reaction; beta-thalassemia; allogeneic hematopoietic stem cell transplantation; osteoporosis; hypogonadism; hepatitis c virus; drug treatment failure; erythrocyte transfusion; genetic screening; bacterial infection; anaphylaxis; disease exacerbation; ribavirin; infection risk; deferoxamine; autologous hematopoietic stem cell transplantation; arthropathy; cardiomyopathy; globins; beta globin; osteopenia; deferasirox; iron overload; agranulocytosis; phlebotomy; cell based gene therapy; deferiprone; iron blood level
Journal Title: Human Gene Therapy
Volume: 18
Issue: 1
ISSN: 1043-0342
Publisher: Mary Ann Liebert, Inc  
Date Published: 2007-01-01
Start Page: 1
End Page: 9
Language: English
DOI: 10.1089/hum.2006.151
PUBMED: 17173507
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 22" - "Export Date: 17 November 2011" - "CODEN: HGTHE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Farid Boulad
    329 Boulad
  2. Michel W J Sadelain
    583 Sadelain
  3. Isabelle C Riviere
    240 Riviere